Research provides new clues about iron toxicity in Parkinson’s disease and explains the paradoxical effect of deferiprone
The results contrast with those of 4 previous independent clinical trials and could provide relevant information on the role of iron accumulation in the process of neurodegeneration. Treatment with deferiprone in patients with early Parkinson's disease who have not yet received treatment with levodopa...